The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,828.00
Bid: 1,828.00
Ask: 1,834.00
Change: -12.00 (-0.65%)
Spread: 6.00 (0.328%)
Open: 1,844.00
High: 1,844.00
Low: 1,824.00
Prev. Close: 1,840.00
RCP Live PriceLast checked at -
RIT Capital Partners is an Investment Trust

To invest in a widely diversified, international portfolio across a range of asset classes, both quoted and unquoted; to allocate part of the portfolio to exceptional managers in order to ensure access to the best external talent available.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

15 Dec 2022 07:00

RNS Number : 7549J
RIT Capital Partners PLC
15 December 2022
 

 

 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

15 December 2022

 

30 November 2022 Net Asset Value and Commentary

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 30 November 2022 (with debt at fair value) was 2,454p per £1 ordinary share (31 October 2022: 2,420p).

For the month of November, this represented an increase in net assets of +1.4%. This equates to a NAV total return of -7.8% over one year, +30.9% over three years and +47.4% over five years. In comparison, the MSCI ACWI (50% Sterling) returned -5.8% over one year, +26.0% over three years and +44.6% over five years.

The key drivers for November's performance were:

- Chinese domestic funds, recovering from October lows to significantly outperform;

- Absolute return and credit funds, as well as real assets, contributed positively;

- Sterling's strength versus the US Dollar was a detractor; and

- The private investment portfolio gave back some of its previous strong gains as Q3 valuations came in; over 92% of the private funds portfolio is now marked to 30 September valuations.

Overall:

- RIT continues to outperform when both rising and falling markets are taken into account, with three and five-year performance producing returns in excess of broad equity markets and with less risk;

- We maintain a diversified and integrated portfolio, investing across a range of asset classes, both quoted and unquoted. These elements are combined with an active risk management framework, as the foundation of our long-standing portfolio construction philosophy; and

- This has driven RIT's long-term performance, with an annualised total return to shareholders of 11.4% compared to the ACWI equity index of 7.2% since our inception.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVDZLFFLLLXFBL
Date   Source Headline
21st Apr 20237:00 amRNSTransaction in Own Shares
20th Apr 20237:00 amRNSTransaction in Own Shares
19th Apr 20237:00 amRNSMarch Net Asset Value and Q1 2023 Commentary
18th Apr 20237:00 amRNSTransaction in Own Shares
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20237:00 amRNSTransaction in Own Shares
12th Apr 20237:00 amRNSTransaction in Own Shares
11th Apr 202312:48 pmRNSInitiation from QuotedData
11th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 202312:19 pmRNSTotal Voting Rights
3rd Apr 20237:00 amRNSLord Rothschild's Foundation % holding increase
3rd Apr 20237:00 amRNSChairman purchases additional shares
3rd Apr 20237:00 amRNSTransaction in Own Shares
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20237:00 amRNSTransaction in Own Shares
28th Mar 20237:00 amRNSTransaction in Own Shares
27th Mar 202312:23 pmRNSTotal Voting Rights
27th Mar 20237:00 amRNSTransaction in Own Shares
24th Mar 20237:00 amRNSTransaction in Own Shares
23rd Mar 20237:00 amRNSTransaction in Own Shares
22nd Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20237:00 amRNSTransaction in Own Shares
20th Mar 20237:00 amRNSTransaction in Own Shares
17th Mar 20237:00 amRNSTransaction in Own Shares
16th Mar 20237:00 amRNSTransaction in Own Shares
15th Mar 20237:00 amRNSTransaction in Own Shares
14th Mar 20237:00 amRNSNet Asset Value(s)
13th Mar 202312:51 pmRNSUpdate on Silicon Valley Bank
8th Mar 20231:21 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSTransaction in Own Shares
7th Mar 20237:00 amRNSTransaction in Own Shares
6th Mar 20237:00 amRNSTransaction in Own Shares
3rd Mar 20237:00 amRNSTransaction in Own Shares
2nd Mar 20237:00 amRNSTransaction in Own Shares
1st Mar 20237:00 amRNSTransaction in Own Shares
28th Feb 20237:00 amRNSAnnual Financial Report
20th Feb 20237:00 amRNSNet Asset Value(s)
9th Feb 20235:00 pmRNSComposition of Board Committee
7th Feb 20237:00 amRNSNet Asset Value(s)
21st Dec 202212:52 pmRNSDirector/PDMR Shareholding
21st Dec 20227:00 amRNSTransaction in Own Shares
19th Dec 20225:20 pmRNSDirector/PDMR Shareholding
19th Dec 20227:00 amRNSTransaction in Own Shares
16th Dec 20227:00 amRNSTransaction in Own Shares
15th Dec 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.